Patients with catecholaminergic polymorphic ventricular tachycardia due to RyR2 mutations were shown to have impaired insulin secretion and glucose tolerance, and a similar phenotype was observed in knockin mice harboring these human RyR2 mutations [170]. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.